Abstract
The assessment of drug taste is crucial for pediatric treatments so that formulations can be developed to enhance their effectiveness. In this study, in vivo and in vitro methods were applied to evaluate the taste of tablets of three drugs administered to children without taste-masking excipients to treat tropical diseases, namely artesunate-mefloquine (ASMQ), praziquantel (PZQ), and benznidazole (BNZ). In the first method, a model of rat palatability was adapted with recirculation to ensure sample dispersion, and the data were analyzed using ANOVA (single factor, 95%). The taste assessment results (in vivo) indicated an aversion to the three medicines, denoted by the animals retracting themselves to the bottom of the box after the first contact with the drugs. For the placebo samples, the animals behaved normally, indicating that taste perception was acceptable. The second method was based on the in vitro analysis of capacitance data from a homemade impedimetric electronic tongue. Consistent with the in vivo taste assessment results, the data points obtained with PZQ, ASMQ, and BNZ were far away from those of their placebos in a map built with the multidimensional projection technique referred to as Interactive Document Mapping (IDMAP). A combined analysis of the results with the two methods allowed us to confirm the bitterness of the three drugs, also pointing to electronic tongues as a promising tool to replace in vivo palatability tests.
Graphical abstract
Similar content being viewed by others
Change history
31 January 2022
A Correction to this paper has been published: https://doi.org/10.1208/s12249-022-02216-w
References
Rees CA, Hotez PJ, Monuteaux MC, Niescierenko M, Bourgeois FT. Neglected tropical diseases in children: an assessment of gaps in research prioritization. PLoS Negl Trop Dis. 2019;13:1–14. https://doi.org/10.1371/journal.pntd.0007111.
WHO, Schistosomiasis in children_ a major public health problem, (2017) 1–3. https://www.pediatricpraziquantelconsortium.org/schistosomiasis. Accessed 12 Feb 2021.
World Health Organisation, Chagas disease (also known as American trypanosomiasis), Chagas Dis. Fact Sheets. (2020) 6. https://www.who.int/news-room/fact-sheets/detail/chagas-disease-(american-trypanosomiasis), https://www.who.int/en/news-room/fact-sheets/detail/chagas-disease-(american-trypanosomiasis). Accessed 19 Jan 2021.
Winzenburg G, Desset-Brèthes S. Industry perspective on palatability testing in children—two case studies. Int J Pharm. 2012;435:139–42. https://doi.org/10.1016/j.ijpharm.2012.05.057.
WHO, Promoting rational use of medicines: core components, WHO Policy Perspect. Med. (2002) 1–6. http://www.msh.org/.
E. Finney, Children’s medicines: a situational analysis, (2011) 1–23. http://www.who.int/childmedicines/progress/CM_analysis.pdf. Accessed 18 Jan 2021.
Garruti S, Garruti S, Estudos de palatabilidade de medicamentos: análise sensorial e aceitabilidade de formulações pediátricas Palatability studies of oral formulations: an overview about drug acceptance in pediatrics RESUMO. 2018;6:44–53. https://doi.org/10.22239/2317-269x.01011.
Barton EN. Hiv/Aids. West Indian Med J. 2013;62:281–2. https://doi.org/10.5005/jp/books/11420_23.
Thompson C, Lombardi D, Sjostedt P, Squires L. Best practice recommendations regarding the assessment of palatability and swallowability in the development of oral dosage forms for pediatric patients. Ther Innov Regul Sci. 2015;49:647–58. https://doi.org/10.1177/2168479015573585.
Ternik R, Liu F, Bartlett JA, Khong YM, Thiam Tan DC, Dixit T, Wang S, Galella EA, Gao Z, Klein S. Assessment of swallowability and palatability of oral dosage forms in children: report from an M-CERSI pediatric formulation workshop. Int J Pharm. 2018;536:570–81. https://doi.org/10.1016/j.ijpharm.2017.08.088.
Dyminski DS, Paterno LG, Takeda HH, Bolini HMA, Mattoso LHC, Cândido LMB. Correlation between human panel and electronic tongue responses on the analysis of commercial sweeteners. Sens Lett. 2006;4:403–8. https://doi.org/10.1166/sl.2006.055.
Bala R, Badjatya S, Madaan R. Strategies practiced to perk up oral palatability and acceptance of bitter drugs. J Drug Deliv Sci Technol. 2020;56: 101580. https://doi.org/10.1016/j.jddst.2020.101580.
Haraguchi T, Yoshida M, Kojima H, Uchida T. Usefulness and limitations of taste sensors in the evaluation of palatability and taste-masking in oral dosage forms, Asian. J Pharm Sci. 2016;11:479–85. https://doi.org/10.1016/j.ajps.2016.03.001.
European Medicines Agency (EMA), Guideline on pharmaceutical development of medicines for paediatric use, (2013). https://www.ema.europa.eu/en/human-regulatory/research-development/paediatric-medicines/paediatric-investigation-plans/paediatric-formulations#:~:text=Guidelineonpharmaceuticaldevelopmentof,population%2Coraspecificsubset. (accessed January 15, 2021).
Soto J, Winzenburg G, Turner R, Desset-Brèthes S, Sheng Y, Orlu-Gul M, Tuleu C. Assessing the bitter taste of medicines: a comparison between rat taste panels (via the brief-access taste aversion (BATA) model) and human taste panels. Int J Pharm. 2016;511:1127–8. https://doi.org/10.1016/j.ijpharm.2016.06.063.
Tiwari RV, Polk AN, Patil H, Ye X, Pimparade MB, Repka MA. Rat palatability study for taste assessment of caffeine citrate formulation prepared via hot-melt extrusion technology. AAPS PharmSciTech. 2017;18:341–8. https://doi.org/10.1208/s12249-015-0447-1.
Noorjahan A, Amrita B, Kavita S. In vivo evaluation of taste masking for developed chewable and orodispersible tablets in humans and rats. Pharm Dev Technol. 2014;19:290–5. https://doi.org/10.3109/10837450.2013.778870.
Münster M, Mohamed-Ahmed AHA, Immohr LI, Schoch C, Schmidt C, Tuleu C, Breitkreutz J. Comparative in vitro and in vivo taste assessment of liquid praziquantel formulations. Int J Pharm. 2017;529:310–8. https://doi.org/10.1016/j.ijpharm.2017.06.084.
Soto J, Keeley A, Keating AV, Mohamed-Ahmed AHA, Sheng Y, Winzenburg G, Turner R, Desset-Brèthes S, Orlu M, Tuleu C. Rats can predict aversiveness of active pharmaceutical ingredients. Eur J Pharm Biopharm. 2018;133:77–84. https://doi.org/10.1016/j.ejpb.2018.09.027.
Keating AV, Soto J, Forbes C, Zhao M, Craig DQM, Tuleu C. Multi-methodological quantitative taste assessment of anti-tuberculosis drugs to support the development of palatable paediatric dosage forms, Pharmaceutics. 2020;12. https://doi.org/10.3390/pharmaceutics12040369.
Preis M, Eckert C, Häusler O, Breitkreutz J. A comparative study on solubilizing and taste-masking capacities of hydroxypropyl-β-cyclodextrin and maltodextrins with high amylose content. Sensors Actuators, B Chem. 2014;193:442–50. https://doi.org/10.1016/j.snb.2013.12.005.
Devantier HR, Long DJ, Brennan FX, Carlucci SA, Hendrix C, Bryant RW, Salemme FR, Palmer RK. Quantitative assessment of TRPM5-dependent oral aversiveness of pharmaceuticals using a mouse brief-access taste aversion assay. Behav Pharmacol. 2008;19:673–82. https://doi.org/10.1097/FBP.0b013e3283123cd6.
Rudnitskaya A, Kirsanov D, Blinova Y, Legin E, Seleznev B, Clapham D, Ives RS, Saunders KA, Legin A. Assessment of bitter taste of pharmaceuticals with multisensor system employing 3 way PLS regression. Anal Chim Acta. 2013;770:45–52. https://doi.org/10.1016/j.aca.2013.02.006.
Ito M, Ikehama K, Yoshida K, Haraguchi T, Yoshida M, Wada K, Uchida T. Bitterness prediction of H1-antihistamines and prediction of masking effects of artificial sweeteners using an electronic tongue. Int J Pharm. 2013;441:121–7. https://doi.org/10.1016/j.ijpharm.2012.11.047.
Preis M, Grother L, Axe P, Breitkreutz J. In-vitro and in-vivo evaluation of taste-masked cetirizine hydrochloride formulated in oral lyophilisates. Int J Pharm. 2015;491:8–16. https://doi.org/10.1016/j.ijpharm.2015.06.002.
Nakamura H, Uchida S, Sugiura T, Namiki N. The prediction of the palatability of orally disintegrating tablets by an electronic gustatory system. Int J Pharm. 2015;493:305–12. https://doi.org/10.1016/j.ijpharm.2015.07.056.
Mohamed-Ahmed AHA, Soto J, Ernest T, Tuleu C. Non-human tools for the evaluation of bitter taste in the design and development of medicines: a systematic review. Drug Discov Today. 2016;21:1170–80. https://doi.org/10.1016/j.drudis.2016.05.014.
Anand V, Kataria M, Kukkar V, Saharan V, Choudhury PK. The latest trends in the taste assessment of pharmaceuticals. Drug Discov Today. 2007;12:257–65. https://doi.org/10.1016/j.drudis.2007.01.010.
Riul A, Dantas CAR, Miyazaki CM, Oliveira ON. Recent advances in electronic tongues. Analyst. 2010;135:2481–95. https://doi.org/10.1039/c0an00292e.
Ciosek P, Wróblewski W. Sensor arrays for liquid sensing - electronic tongue systems. Analyst. 2007;132:963–78. https://doi.org/10.1039/b705107g.
Ono N, Miyamoto Y, Ishiguro T, Motoyama K, Hirayama F, Iohara D, Seo H, Tsuruta S, Arima H, Uekama K. Reduction of bitterness of antihistaminic drugs by complexation with β-cyclodextrins. J Pharm Sci. 2011;100:1935–43. https://doi.org/10.1002/jps.22417.
Giacometti JA, Shimizu FM, Carr O, Oliveira ON, A guiding method to select and reduce the number of sensing units in electronic tongues, in, . IEEE SENSORS. IEEE. 2016;2016:1–3. https://doi.org/10.1109/ICSENS.2016.7808663.
Minghim R, Paulovich FV, de Andrade Lopes A. Content-based text mapping using multi-dimensional projections for exploration of document collections. Vis Data Anal. 2006;2006(6060):60600S. https://doi.org/10.1117/12.650880.
Paulovich FV, Moraes ML, Maki RM, Ferreira M, Oliveira ON, De Oliveira MCF. Information visualization techniques for sensing and biosensing. Analyst. 2011;136:1344–50. https://doi.org/10.1039/c0an00822b.
Yagnesh TNS, Rada SK. Oral dissolving films: an effective tool for fast therapeutic action. Journal of Drug Delivery and Therapeutics Oral dissolving films: an effective tool for fast therapeutic action. 2019. https://doi.org/10.22270/jddt.v9i1-s.2395.
Bajpai SK, Shah FF, Bajpai M, Jadaun M. Dynamic release of amoxicillin from orally dissolving film (ODF) composed of casein and sodium alginate. Sci Forschen J Drug Res Dev. 2017:1–7.
Steiner JE, Glaser D, Hawilo ME, Berridge KC. Comparative expression of hedonic impact: affective reactions to taste by human infants and other primates. Neurosci Biobehav Rev. 2001;25:53–74. https://doi.org/10.1016/S0149-7634(00)00051-8.
L.F. DA GAMA, Avaliação da palatabilidade do praziquantel, Universidade Federeal Fluminense. 2018.
Woertz K, Tissen C, Kleinebudde P, Breitkreutz J. Performance qualification of an electronic tongue based on ICH guideline Q2. J Pharm Biomed Anal. 2010;51:497–506. https://doi.org/10.1016/j.jpba.2009.09.029.
Machado JC, Shimizu FM, Ortiz M, Pinhatti MS, Carr O, Guterres SS, Oliveira ON, Volpato NM. Efficient praziquantel encapsulation into polymer microcapsules and taste masking evaluation using an electronic tongue. Bull Chem Soc Jpn. 2018;91:865–74. https://doi.org/10.1246/bcsj.20180005.
Acknowledgements
The authors are grateful for the financial support by PAPES VII, PROEP/FAR/CNPq/Fiocruz, CNPQ, and FAPESP (2018/22214-6). Also, we would like to thank Luciano Simoes Pereira for all support with the image treatment and the recirculation system construction. The authors also thank Angelo L. Gobbi and Maria H. O. Piazzetta for their technical assistance in the microfabrication laboratory (LMF/LNNano/CNPEM).
Author information
Authors and Affiliations
Contributions
Conceptualization: J.B., A.L.V., R.G.S.T., S.C.E.
Experimental procedure: J.B., R.G.S.T., L.P.S.R., I.A.M.F., T.A.V.G., O. C., A.K.M.S., K.C.O
Data curation: J.B., R.G.S.T., F.M.S., M.R.R.T.
Writing-original draft preparation: J.B., F.M.S., M.R.R.T.
Review and editing: J.B., F.M.S., A.L.V, L.B.d.F., O.N.O. Jr., S.C.E.,
Review: F.M.L.D., F.C.A
Supervision: A.L.V, S.C.E, O.N.O. Jr.
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article was updated to correct Tables 1 and 2.
Rights and permissions
About this article
Cite this article
Boniatti, J., Tappin, M.R.R., da S Teixeira, R.G. et al. In Vivo and In Vitro Taste Assessment of Artesunate-Mefloquine, Praziquantel, and Benznidazole Drugs for Neglected Tropical Diseases and Pediatric Patients. AAPS PharmSciTech 23, 22 (2022). https://doi.org/10.1208/s12249-021-02162-z
Received:
Accepted:
Published:
DOI: https://doi.org/10.1208/s12249-021-02162-z